EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Currently available prostanoids for the treatment of glaucoma and ocular hypertension: A review

Betsy Benitez, Abdelrahman M Anter, Jennifer Arcuri, Sanjoy K Bhattacharya

Current Opinion in Pharmacology · 2024-02 · 74 · 102424

DOI: 10.1016/j.coph.2023.102424 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Opinion in Pharmacology, 2024-02. Verfasst von Betsy Benitez und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, 33136, USA; Miami Integrative Met…. Hauptthemen laut MEDLINE: Glaucoma, Open-Angle, Glaucoma, Ocular Hypertension. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NEI NIH HHS, National Eye Institute, Research to Prevent Blindness.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent advancements in prostaglandin analogs (PGAs) have reinforced their role in managing intraocular pressure (IOP). Latanoprost excels in 24-h IOP control, while various PGAs offer similar effectiveness and side effects, generic PGAs perform as well as branded ones, and a notable IOP rise observed upon PGA discontinuation. Formulations with or without preservatives show comparable IOP reduction and adherence, often surpassing benzalkonium chloride (BAK)-preserved options. Emergent PGAs, such as latanoprostene bunod, fixed-dose netarsudil combined with latanoprost, and omidenepag Isopropyl, offer enhanced or non-inferior IOP reduction. The bimatoprost implant introduces a novel administration method with effective IOP reduction. These developments underscore ongoing progress in PGA-focused ophthalmological research. This article offers a comprehensive review of available prostanoid analogs and explores new developments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glaucoma, Open-AngleGlaucomaOcular HypertensionHumansLatanoprostAntihypertensive AgentsOphthalmic SolutionsIntraocular PressureProstaglandins, SyntheticTreatment Outcome

Substanzen

LatanoprostAntihypertensive AgentsOphthalmic SolutionsProstaglandins, Synthetic

Autor:innen und Institutionen

  • Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, 33136, USA; Miami Integrative Metabolomics Research Center, Miami, FL, 33136, USA.
  • Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, 33136, USA; Miami Integrative Metabolomics Research Center, Miami, FL, 33136, USA; Graduate Program in…

Förderung

  • NEI NIH HHS
  • National Eye Institute
  • Research to Prevent Blindness
  • Glaucoma Foundation

Zitieren

APA

Benitez, B., Anter, A. M., Arcuri, J., & Bhattacharya, S. K. (2024). Currently available prostanoids for the treatment of glaucoma and ocular hypertension: A review. Current Opinion in Pharmacology, 74, 102424. https://doi.org/10.1016/j.coph.2023.102424

Vancouver

Benitez B, Anter AM, Arcuri J, Bhattacharya SK. Currently available prostanoids for the treatment of glaucoma and ocular hypertension: A review. Current Opinion in Pharmacology. 2024;74:102424. doi:10.1016/j.coph.2023.102424

BibTeX
@article{Benitez2024,
  author = {Benitez, Betsy and Anter, Abdelrahman M and Arcuri, Jennifer and Bhattacharya, Sanjoy K},
  title = {Currently available prostanoids for the treatment of glaucoma and ocular hypertension: A review},
  journal = {Current Opinion in Pharmacology},
  year = {2024},
  volume = {74},
  pages = {102424},
  doi = {10.1016/j.coph.2023.102424}
}
Kostenlos starten →